Walgreens Boots Alliance (WBA.US) has expressed interest in selling all or part of its holdings in primary care provider VillageMD.
According to the financial news app Zhitongcaijing, Walgreens Boots Alliance (WBA.US) has said that it is evaluating the majority of its investment in primary care provider VillageMD and may sell all or part of its shares in VillageMD. Walgreens added that restructuring and other strategic opportunities are also under discussion.
VillageMD is a core part of Walgreens Boots Alliance's expansion beyond traditional pharmacy business. The company has already planned to close a large number of poorly performing clinics to cut costs.
According to a filing with the SEC, Walgreens Boots Alliance said it is considering several options due to the "significant current and anticipated future cash demands of VillageMD." As early as the end of June, CEO Tim Wentworth mentioned plans to reduce shareholding in VillageMD.
In addition, Walgreens Boots Alliance has reached a forbearance agreement with VillageMD regarding a $2.25 billion secured loan that the latter had defaulted on. Stakeholders of both companies and other third parties have discussed the future of Walgreens Boots Alliance's investment in VillageMD.
It is worth noting that Walgreens Boots Alliance released mixed Q3 earnings in June, and due to weak consumer spending damaging retail trade, the company lowered its 2024 financial year guidance and said it may close underperforming U.S. stores. The company fell 15% following the report.
CEO Tim Wentworth warned, "We continue to face a challenging operating environment, including ongoing pressure on the American consumer and recent market dynamics impacting our Pharmacy profitability."
On August 5, Walgreens Boots Alliance stock fell to a 52-week low of $10.62. The company's stock has fallen about 58% so far this year. As of the time of writing, the company had fallen 1.19% to $10.78.